Effect of phenobarbitone and pre-eclamptic toxaemia on neonatal jaundice.
作者信息
Powell J, Waterhouse J, Culley P, Wood B
出版信息
Lancet. 1969 Oct 11;2(7624):802. doi: 10.1016/s0140-6736(69)90518-2.
PMID:4186048
Abstract
摘要
相似文献
1
Effect of phenobarbitone and pre-eclamptic toxaemia on neonatal jaundice.
Lancet. 1969 Oct 11;2(7624):802. doi: 10.1016/s0140-6736(69)90518-2.
2
Barbiturate and hyperbilirubinaemia of prematurity.
Lancet. 1969 Mar 15;1(7594):548-50. doi: 10.1016/s0140-6736(69)91958-8.
3
Phenobarbitone for neonatal jaundice.苯巴比妥用于新生儿黄疸。
Lancet. 1969 May 31;1(7605):1098. doi: 10.1016/s0140-6736(69)91732-2.
4
Phenobarbitone and dicophane in jaundice.
Lancet. 1969 Jul 19;2(7612):144-5.
5
Phenobarbitone prophylaxis for neonatal hyperbilirubinemia.苯巴比妥预防新生儿高胆红素血症。
Pediatrics. 1971 Sep;48(3):372-6.
6
Decrease of total serum-bilirubin concentration in newborn infants after phenobarbitone treatment.苯巴比妥治疗后新生儿血清总胆红素浓度降低。
Lancet. 1968 Sep 28;2(7570):705-8. doi: 10.1016/s0140-6736(68)90750-2.
7
Jaundice of the newborn and phenobarbitone.
Lancet. 1971 Jan 16;1(7690):119-20.
8
Treatment of neonatal jaundice with phenobarbitone.用苯巴比妥治疗新生儿黄疸。
Gut. 1969 May;10(5):414.
9
Zotero 插件